Amustaline/glutathione pathogen‐reduced red cell hemoglobin utilization in complex cardiac surgery: A post hoc analysis of the phase 3 <scp>ReCePI</scp> trial
Test patients required less transfused Hb than control subjects to maintain equivalent daily hemoglobin levels following similar blood loss.
Authors
- Richard J. Benjamin (ORCID: https://orcid.org/0000-0001-6618-4744)
- Thomas Gniadek
- James D. Gorham (ORCID: https://orcid.org/0000-0003-3711-2607)
- Michael Sekela (ORCID: https://orcid.org/0000-0002-4981-9039)
- Stanley Bentow
- John S. McNeil (ORCID: https://orcid.org/0000-0002-2351-5459)
- Nina Mufti
- Edward L. Snyder (ORCID: https://orcid.org/0000-0003-1175-5479)
- Laurence Corash (ORCID: https://orcid.org/0000-0002-8615-9869)
- Kathy Y Liu (ORCID: https://orcid.org/0000-0002-7482-2758)
- Ian J. Welsby (ORCID: https://orcid.org/0000-0002-2789-5612)
Institutions
- University of Kentucky (US)
- University of Virginia Health System (US)
- Yale University (US)
- Duke Medical Center (US)
- Cerus (United States) (US)
Publication Details
- Journal
- Transfusion
- Published
- 2025-11-29
- DOI
- https://doi.org/10.1111/trf.70009
- Primary Topic
- Blood transfusion and management
- Type
- article
- Field-Weighted Citation Impact
- 0.00